Conference item
Glucosidase inhibitors induce HCV glycoproteins misfolding, impair viral assembly and release, and reduce the infectivity of residually secreted HCV particles
- Abstract:
- Novel anti-HCV molecules are still needed to better combat HCV infection. Molecules targeting specifically viral activities are the most attractive in terms of drug development and are therefore the most studied. The antiviral properties of glucosidase inhibitors were established using the most relevant models currently available.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Bibliographic Details
- Publisher:
- Wiley Publisher's website
- Volume:
- 44
- Issue:
- 4
- Pages:
- 198A-198A
- Host title:
- 57th Annual Meeting of the American Association for the Study of Liver Diseases
- Publication date:
- 2006-10-01
- DOI:
- EISSN:
-
1527-3350
- ISSN:
-
0270-9139
- Source identifiers:
-
100492
Item Description
- Pubs id:
-
pubs:100492
- UUID:
-
uuid:133cb2f7-ea3e-422a-b547-5b1491b7c587
- Local pid:
- pubs:100492
- Deposit date:
- 2012-12-19
Terms of use
- Copyright holder:
- American Association for the Study of Liver Diseases
- Copyright date:
- 2006
- Notes:
- © 2006 American Association for the Study of Liver Diseases. Published by Wiley on behalf of the AASLD. This is the accepted manuscript version of the article. The final version is available online from the American Association for the Study of Liver Diseases at: [10.1002/hep.21395]
If you are the owner of this record, you can report an update to it here: Report update to this record